GeneDx Holdings (WGS): Wutah pendapatan kuartal marang kuartal

Logo korporat perusahaan genedx.com (WGS)

GeneDx Holdings Corp. (WGS) generates stable income based on the integration of DNA tests into medical protocols, as confirmed by the GURU.Markets daily chart, where the quarterly revenue growth rate reaches 5.60, reflecting today's metric value. Proprietary algorithms and complex certifications drive this growth by limiting the entry of new players. Expanding demand for newborn genome sequencing further strengthens the company's market position.

WGS (Sema4) riwayat Owah-owahan pendapatan dibandhingake kuartal kepungkur saka 28.04.2023 nganti 21.11.2026

Rincian analitis perusahaan GeneDx (WGS)

- rega saham lan target rega konsensus:
- data kapitalisasi bursa:
Analisis wiwitan perusahaan:WGS - GeneDx Holdings
Barang unggulan genedx.com

This indicator measures the rate of revenue change between consecutive quarters, eliminating accounting smoothing and exposing real-time demand dynamics. By analyzing the quarterly revenue growth rate, an investor can promptly detect sales stagnation at GeneDx Holdings Corp. (WGS), driven by aggressive dumping from network laboratories and fierce price competition within the genetic testing sector.

Pesaing utama

TEM - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal qiagen.com QGEN|IONS: Wutah pendapatan triwulanan|Repligen Corp - Tambahing pendapatan triwulanan|RNA (Avidity Corp) - Wutah pendapatan triwulanan|CRISPR Therapeutics Corp - Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan triwulanan RARE|Owah-owahan dodolan kuartal marang kuartal BEAM|Wutah pendapatan triwulanan SRPT (Sarepta Corp)|TWST - Wutah dodolan triwulanan|TXG: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Intellia Therapeutics|STOK: Wutah pendapatan triwulanan|BLFS - Tingkat wutah dodolan sajrone kuartal|Wutah dodolan triwulanan WVE|MAZE: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Sionna Corp (SION)|Tingkat wutah dodolan sajrone kuartal Prime Medicine Bio|Wutah pendapatan triwulanan TSHA (Taysha Gene Therapies Inc)|Wutah pendapatan triwulanan uniqure.com QURE|MeiraGTx Holdings - Wutah pendapatan triwulanan|RGNX - Wutah pendapatan triwulanan|SLDB (Solid Corp) - Wutah dodolan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Ocugen Corp OCGN|PACB (Pacific Biosciences) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal BNTC|Wutah pendapatan triwulanan DSGN|Wutah dodolan triwulanan Rocket Pharma RCKT|Tingkat wutah dodolan sajrone kuartal FDMT|Wutah pendapatan triwulanan Lexeo Therapeutics LXEO|KRRO - Wutah pendapatan kuartal marang kuartal|EDIT (Editas Medicine, Inc.) - Wutah dodolan kuartal marang kuartal|SLN: Wutah pendapatan triwulanan|ProQR - Tambahing pendapatan triwulanan|CDXS (Codexis) - Wutah pendapatan triwulanan|Sangamo (SGMO) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan NAUT|Wutah dodolan triwulanan Metagenomi, Inc. MGX|Wutah pendapatan kuartal marang kuartal Precision BioSciences DTIL|Tambahing pendapatan triwulanan GBIO|BOLD - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Wutah pendapatan kuartal marang kuartal|RXi Pharmaceuticals - Tambahing pendapatan triwulanan|MBIO (Mustang Bio) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal RNAZ (transcodetherapeutics.com)|Wutah pendapatan kuartal marang kuartal Bionano (BNGO)|Applied DNA Sciences - Wutah dodolan kuartal marang kuartal|Wutah pendapatan triwulanan BLUE (bluebirdbio.com)|ImmunoPrecise Antibodies (IPA) - Tingkat wutah pendapatan sajrone kuartal|omegatherapeutics.com - Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Singular Genomics Systems Inc (OMIC)|RGLS: Wutah pendapatan triwulanan|Syros Pharmaceuticals, Inc (SYRS) - Wutah pendapatan triwulanan|TBIO (telesisbio.com) - Wutah pendapatan triwulanan|TCON: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Unity Biotechnology, Inc (UBX)